Robertson Stephens Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Robertson Stephens Wealth Management's ABBV Position: Q3 2026 in Review
Robertson Stephens Wealth Management increased its AbbVie (ABBV) stake by 0.27% in Q3 2026, buying an estimated $43.3K and bringing the position to 63,926 shares worth $16.7M. The position accounts for 0.4% of the portfolio, ranked #42.
Robertson Stephens Wealth Management first reported a position in ABBV in Q3 2019 and has held it in 29 quarters since. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Robertson Stephens Wealth Management held 63,926 shares of AbbVie worth $16.7M as of Q3 2026.
- Robertson Stephens Wealth Management bought 169 AbbVie shares in Q3 2026, an estimated $43.3K.
- AbbVie made up 0.4% of Robertson Stephens Wealth Management's portfolio in Q3 2026, its #42 holding.
- Robertson Stephens Wealth Management first reported a position in AbbVie in Q3 2019 and has held it in 29 quarters since.
- 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Robertson Stephens Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.